Peter DeMuth

Chief Tech/Sci/R&D Officer at ELICIO THERAPEUTICS, INC.

Net worth: - $ as of 30/05/2024

38 year

Health Technology

Finance

Consumer Services

Peter DeMuth active positions

Companies	Position	Start	End
ELICIO THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	31/12/2021	-

Companies	Position	Start	End
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	31/07/2017	31/05/2023

Massachusetts Institute of Technology	Doctorate Degree
University of Maryland	Undergraduate Degree

International

United States

Operational

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
ELICIO THERAPEUTICS, INC.	Health Technology

Private companies	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Private companies

Health Technology